Predicting clinical outcomes in neuroblastoma with genomic data integration

BACKGROUND: Neuroblastoma is a heterogeneous disease with diverse clinical outcomes. Current risk group models require improvement as patients within the same risk group can still show variable prognosis. Recently collected genome-wide datasets provide opportunities to infer neuroblastoma subtypes i...

Descripción completa

Detalles Bibliográficos
Autores principales: Baali, Ilyes, Acar, D Alp Emre, Aderinwale, Tunde W., HafezQorani, Saber, Kazan, Hilal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889397/
https://www.ncbi.nlm.nih.gov/pubmed/30621745
http://dx.doi.org/10.1186/s13062-018-0223-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889397/
https://www.ncbi.nlm.nih.gov/pubmed/30621745
http://dx.doi.org/10.1186/s13062-018-0223-8

Ejemplares similares